Literature DB >> 34915603

Association of Patient and Primary Care Provider Factors with Outpatient COPD Care Quality.

Thomas L Keller1, Jennifer Wright2, Lucas M Donovan1,3, Laura J Spece1,3, Kevin Duan1, Nadiyah Sulayman3, Alexandria Dominitz3, J Randall Curtis1,4, David H Au1,3, Laura C Feemster1,3.   

Abstract

RATIONALE: Large gaps exist between guideline-recommended outpatient chronic obstructive pulmonary disease (COPD) care and clinical practice. Seeking to design effective interventions, we identified patient and primary care provider (PCP) characteristics associated with receiving evidence-based COPD care.
METHODS: We performed an observational study of adults aged ≥ 40 years with clinically diagnosed COPD who received care at 2 University of Washington-affiliated primary care clinics between June 1, 2011, and June 1, 2013. Our primary outcome was the proportion of evidence-based outpatient COPD quality measures received through primary or pulmonary care. Among all patients, we assessed spirometry completion, respiratory symptom identification, smoking status ascertainment, oxygen saturation measurement, and guideline-concordant inhaled therapy prescription. We also determined confirmation of airflow obstruction, oxygen prescription, smoking cessation intervention, and pulmonary rehabilitation referral if eligible. We used multivariable mixed effects linear regression to estimate the association of patient and PCP characteristics with the primary outcome.
RESULTS: Among 641 patients, 382 were male (59.6%) with mean age 63.6 (standard deviation [SD] 10.6) years. Most patients currently smoked (N=386, 60.2%). Patients saw 150 unique PCPs during 5.3 (SD 3.2) PCP visits, with 107 completing pulmonary referrals (16.7%). Patients received 67.5% (SD 18.4%) of eligible (median 7 [interquartile range 6-7]) evidence-based quality measures. After adjustment, pulmonary referral was associated with a higher receipt of outpatient quality measures (ß117.7%, 95% confidence interval: 12.6%, 22.7%). Patient demographics, comorbidities, and PCP identity/characteristics were not associated with outpatient care quality.
CONCLUSIONS: The quality of outpatient COPD care was suboptimal. Future studies should investigate if engaging pulmonologists in COPD management improves care quality. JCOPDF
© 2021.

Entities:  

Keywords:  bronchodilator agents; chronic obstructive pulmonary disease; quality of health care; spirometry

Year:  2022        PMID: 34915603      PMCID: PMC8893974          DOI: 10.15326/jcopdf.2021.0232

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN: 2372-952X


  53 in total

1.  Multicollinearity in hierarchical linear models.

Authors:  Han Yu; Shanhe Jiang; Kenneth C Land
Journal:  Soc Sci Res       Date:  2015-05-19

2.  Total and state-specific medical and absenteeism costs of COPD among adults aged ≥ 18 years in the United States for 2010 and projections through 2020.

Authors:  Earl S Ford; Louise B Murphy; Olga Khavjou; Wayne H Giles; James B Holt; Janet B Croft
Journal:  Chest       Date:  2015-01       Impact factor: 9.410

3.  The quality of obstructive lung disease care for adults in the United States as measured by adherence to recommended processes.

Authors:  Richard A Mularski; Steven M Asch; William H Shrank; Eve A Kerr; Claude M Setodji; John L Adams; Joan Keesey; Elizabeth A McGlynn
Journal:  Chest       Date:  2006-12       Impact factor: 9.410

Review 4.  Effectiveness and success factors of educational inhaler technique interventions in asthma & COPD patients: a systematic review.

Authors:  Sven L Klijn; Mickaël Hiligsmann; Silvia M A A Evers; Miguel Román-Rodríguez; Thys van der Molen; Job F M van Boven
Journal:  NPJ Prim Care Respir Med       Date:  2017-04-13       Impact factor: 2.871

5.  The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of patients with COPD in Taiwan: Taiwan Obstructive Lung Disease (TOLD) study.

Authors:  Meng-Jer Hsieh; Shu-Yi Huang; Tsung-Ming Yang; Chi-Wei Tao; Shih-Lung Cheng; Chao-Hsien Lee; Ping-Hung Kuo; Yao-Kuang Wu; Ning-Hung Chen; Wu-Huei Hsu; Jeng-Yuan Hsu; Ming-Shian Lin; Chin-Chou Wang; Yu-Feng Wei; Ying-Huang Tsai
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-09-25

6.  Reassessment of Home Oxygen Prescription after Hospitalization for Chronic Obstructive Pulmonary Disease. A Potential Target for Deimplementation.

Authors:  Laura J Spece; Eric M Epler; Kevin Duan; Lucas M Donovan; Matthew F Griffith; Stephanie LaBedz; Neeta Thakur; Renda Soylemez Wiener; Jerry A Krishnan; David H Au; Laura C Feemster
Journal:  Ann Am Thorac Soc       Date:  2021-03

7.  Association Between Initiation of Pulmonary Rehabilitation After Hospitalization for COPD and 1-Year Survival Among Medicare Beneficiaries.

Authors:  Peter K Lindenauer; Mihaela S Stefan; Penelope S Pekow; Kathleen M Mazor; Aruna Priya; Kerry A Spitzer; Tara C Lagu; Quinn R Pack; Victor M Pinto-Plata; Richard ZuWallack
Journal:  JAMA       Date:  2020-05-12       Impact factor: 157.335

8.  Variability in adherence to clinical practice guidelines and recommendations in COPD outpatients: a multi-level, cross-sectional analysis of the EPOCONSUL study.

Authors:  Myriam Calle Rubio; José Luis López-Campos; Juan J Soler-Cataluña; Bernardino Alcázar Navarrete; Joan B Soriano; José Miguel Rodríguez González-Moro; Manuel E Fuentes Ferrer; Juan Luis Rodríguez Hermosa
Journal:  Respir Res       Date:  2017-12-02

9.  Geographic Accessibility of Pulmonologists for Adults With COPD: United States, 2013.

Authors:  Janet B Croft; Hua Lu; Xingyou Zhang; James B Holt
Journal:  Chest       Date:  2016-05-21       Impact factor: 9.410

10.  Effect of cardiologist care on 6-month outcomes in patients discharged with heart failure: results from an observational study based on administrative data.

Authors:  Vera Maria Avaldi; Jacopo Lenzi; Stefano Urbinati; Dario Molinazzi; Carlo Descovich; Anselmo Campagna; Martina Taglioni; Angelo Fioritti; Maria Pia Fantini
Journal:  BMJ Open       Date:  2017-11-03       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.